Courage Therapeutics logo — New hope for anorexia nervosa

Courage Therapeutics

New hope for anorexia nervosa

Founded 2019 United States Newton, United States 3 employees Seed Total: $1.00M Biotechnology, Health Care +1

General Information

Company Name Courage Therapeutics
Founded Year 2019
Location United States Newton, United States
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Courage Therapeutics. To contact Courage Therapeutics, visit couragetx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Courage Therapeutics

Courage Therapeutics is a promising biotechnology startup founded in 2019, with a clear mission reflected in its slogan: "New hope for anorexia nervosa." The company is focused on developing innovative medicines for eating disorders, particularly anorexia nervosa. With a recent $1.00M Seed Round investment on 24 March 2021, from Whatif Ventures and Michigan Biomedical Venture Fund, Courage Therapeutics has attracted attention and support from reputable investors. The startup's dedication to addressing critical health issues and its early success in securing investment make it a compelling venture for potential backers in the biotechnology, healthcare, and pharmaceutical industries. Based in the United States, Courage Therapeutics shows promise in making a significant impact on the treatment of eating disorders.

Taxonomy: eating disorders, anorexia nervosa, medicine development, pharmaceutical research, mental health, treatment development, clinical trials, patient support, biology, psychiatry, biopharmaceutical, drug development, mental wellness, therapeutic advancements

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.00M 2
Whatif Ventures, Michigan Biomedical Venture Fund
24 Mar 2021

Courage Therapeutics Alternatives & Competitors

View All Alternatives
Courage Therapeutics vs

By doing research we help bring new advanced drugs to market that enhance the quality of patient’s...

11 employees
Biotechnology, Health Care
Courage Therapeutics vs

Cancer drug development comes of age.

Post-IPO Equity
190 employees
Biopharma, Biotechnology
Courage Therapeutics vs

Pioneering advancements in neuropsychiatric treatment for a brighter future

Series B
11-50 employees
Biotechnology, Health Care

FAQ About Courage Therapeutics

New hope for anorexia nervosa
Courage Therapeutics was founded in 2019.
Courage Therapeutics is headquartered in Newton, United States.
Courage Therapeutics operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on eating disorders, anorexia nervosa, medicine development and pharmaceutical research.
Courage Therapeutics has approximately 3 employees.
Courage Therapeutics has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
Top alternatives and competitors to Courage Therapeutics include Elite Clinical Studies, LLC, Day One Biopharmaceuticals, Chase Pharmaceuticals, Adial Pharmaceuticals, Fabre-Kramer Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Courage Therapeutics and Elite Clinical Studies, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Courage Therapeutics, https://bouncewatch.com/company/courage-therapeutics, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes